| AASLD

23 July 2018

Shunts and bypasses for portal hypertension: Making the right choice

Read more about Shunts and bypasses for portal hypertension: Making the right choice

Riccardo Superina – 23 July 2018

Old Remedies to Heal the Liver: Novel Effects of Digoxin in Hepatic Sterile Inflammation

Read more about Old Remedies to Heal the Liver: Novel Effects of Digoxin in Hepatic Sterile Inflammation

Juan P. Arab, Marco Arrese – 23 July 2018

The middle hepatic vein controversy: Art and science

Read more about The middle hepatic vein controversy: Art and science

Chung Mau Lo – 23 July 2018

Issue Information ‐ Instructions to Authors

Read more about Issue Information ‐ Instructions to Authors

23 July 2018

Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy

Read more about Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy

Maximilian A. Ardelt, Thomas Fröhlich, Emanuele Martini, Martin Müller, Veronika Kanitz, Carina Atzberger, Petra Cantonati, Martina Meßner, Laura Posselt, Thorsten Lehr, Jan‐Georg Wojtyniak, Melanie Ulrich, Georg J. Arnold, Lars König, Dario Parazzoli, Stefan Zahler, Simon Rothenfußer, Doris Mayr, Alexander Gerbes, Giorgio Scita, Angelika M. Vollmar, Johanna Pachmayr – 23 July 2018 – Therapeutic options for patients with advanced‐stage hepatocellular carcinoma (HCC) are very limited.